alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.2


 


AMENDMENT NO. 1 TO SCIENTIFIC ADVISORY BOARD
AGREEMENT


 


THIS AMENDMENT NO. 1 TO SCIENTIFIC ADVISORY
BOARD AGREEMENT (the “Amendment”), is dated as of September 21, 2016, by and between Enumeral Biomedical Holdings,
Inc., a Delaware corporation (with its subsidiaries, the “Company”), and Barry Buckland, Ph.D. (the “Advisor”).
This Amendment amends that certain Scientific Advisory Board Agreement, dated as of September 14, 2014, by and between the Company
and the Advisor (the “SAB Agreement”). Capitalized words used but not otherwise defined herein shall have the meanings
ascribed to such terms in the SAB Agreement.


 


Company and Advisor desire to amend the terms
of the SAB Agreement to extend the term for an additional year. In consideration of the mutual covenants and promises contained
herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree
as follows:


 


		1.	Pursuant to the terms of the SAB Agreement, the Term (as defined in Section 4(a) of the SAB Agreement) is hereby extended until
September 14, 2017.



 


		2.	Except as explicitly set forth herein, the terms and conditions of the Agreement remain unchanged and in full force and effect.



 


[Remainder of Page Intentionally Left Blank]


 




    	 	1	 



     


    

 


IN WITNESS WHEREOF, the parties hereto have
executed this Amendment as of the day and year set forth above.


 


	 	Enumeral Biomedical Holdings, Inc.
	 	 	  
	 	By:	/s/ Kevin G. Sarney 
	 	Name:  Kevin G. Sarney
	 	Title: Vice President of Finance, Chief Accounting Officer and
    Treasurer
	 	 
	 	ADVISOR
	 	 	 
	 	/s/ Barry Buckland, Ph.D.
	 	Name:  Barry Buckland, Ph.D.
Exhibit










AMENDMENT NO. 5 TO 
AMENDED AND RESTATED BYLAWS OF 
IMPAX LABORATORIES, INC., AS AMENDED


The Amended and Restated Bylaws of Impax Laboratories, Inc., as amended (the “Bylaws”) are hereby amended as follows:
		
	1.
	Section 14 of Article III shall be amended and restated in its entirety to read as follows:


“SECTION 14. NUMBER.  The authorized number of directors shall be no less than one nor more than eight. Within the foregoing limits, the number of directors shall be fixed from time to time by resolution adopted by the Board. (Del Code Ann., tit. 8, §§ 141(b)).”
2.Except as expressly modified hereby, the Bylaws and all the provisions contained therein shall remain in full force and effect.
This Amendment No. 5 to the Bylaws was adopted by the Board of Directors of Impax Laboratories, Inc., effective August 19, 2016.


/s/ Mark A. Schlossberg
Name: Mark A. Schlossberg
Title:   Senior VP, General Counsel and Corporate Secretary
EX-4.1



 EXHIBIT 4.1 

AMENDMENT TO 2011 ASHLAND INC. INCENTIVE PLAN 

The 2011 Ashland Inc. Incentive Plan (the “Plan”) is hereby amended, effective as of November 14, 2012 and subject to the approval by the
shareholders of the Company, as follows: 
  

	 	1.	Section 3(A) of the Plan is hereby amended by (i) deleting the number “2,000,000” and replacing it with the number “4,000,000” and (ii) deleting the second sentence thereof. 


 

	 	2.	Section 3 of the Plan is hereby amended by adding the following new Section (C) at the end thereof: 


“(C) Effective with respect to any Awards granted on or after the Company’s 2013 Annual Meeting of Shareholders, any shares of
Common Stock underlying Restricted Stock Awards, Restricted Stock Unit Awards, Merit Awards, Incentive Awards, Performance Unit Awards and Dividend Equivalents (collectively, “Full-Value Awards”) that are issued or delivered under
the Plan shall reduce the shares available under Section 3(A) hereof by 2.2 shares for every one share of Common Stock issued or delivered in connection with such Full-Value Award, and any shares covered by an Award, other than a Full-Value Award,
shall reduce the shares of Common Stock available under the Plan by one share for every one share of Common Stock issued or delivered under such Award. Any shares of Common Stock that again become available for issuance or delivery pursuant to
Section 3(B) of the Plan shall be credited toward the Plan limit as set forth in Section 3(A) hereof in the same manner such shares were originally deducted from the aggregate Plan limit pursuant to this Section 3(C).” 

 

	 	3.	Section 6(C)(2) of the Plan is hereby amended by adding the following sentence to the end thereof: 


“Notwithstanding anything contained in this Section 6(C)(2) to the contrary, cash dividends or other distributions with respect to
Restricted Stock Awards that vest based on the achievement of Performance Goals shall be accumulated until such Award is earned, and the cash dividends or other distributions shall not be paid if the Performance Goals are not satisfied.” 

 

	 	4.	Section 16(M) of the Plan is hereby amended by adding the following sentence to the end thereof: 


“Notwithstanding anything contained in this Plan to the contrary, dividend equivalents with respect to Restricted Stock Unit Awards,
Incentive Awards, Performance Unit Awards and Merit Awards that vest based on the achievement of Performance Goals shall be accumulated until such Award is earned, and the dividend equivalents shall not be paid if the Performance Goals are not
satisfied.” 
  

	 	5.	Section 17 of the Plan is hereby amended by adding the following sentence to the end thereof: 


“No Award may be granted under the Plan after November 14, 2022, or such earlier date as the Board shall determine. The Plan will remain
in effect with respect to outstanding Awards until no Awards remain outstanding.” 
  

	 	6.	Except as explicitly set forth herein, the Plan will remain in full force and effect. 

  

			
		 	ASHLAND INC.
		
	By:	 	 /S/ SUSAN B. ESLER

		 	Susan B. Esler
		 	Chief Human Resources and
		 	Communications Officer
ex10a.htm
















Exhibit (10)(a)

















Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm












We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 12 to the 1933 Act Registration Statement (Form N-4 No. 333-141755) and Amendment No. 38 to the 1940 Act Registration Statement (Form N-4 No. 811-07785), and to the use therein of our reports dated (a) March 31, 2016, with respect to the financial statements of Lincoln Life & Annuity Company of New York and (b) April 27, 2016, with respect to the financial statements of Lincoln Life & Annuity Variable Annuity Account L for the interests in a separate account under group flexible payment deferred variable annuity contracts.


 


/s/ Ernst & Young LLP


 


Philadelphia, Pennsylvania


September 29, 2016
Alisha C. WILLIAMS, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-2976

District Court of Appeal of Florida, Fifth District.

Decision filed February 12, 2019 Rehearing Denied March 21, 2019

AFFIRMED.
# C_2017293EN.01003401.xml

| 4.9.2017 | EN | Official Journal of the European Union | C 293/34 |
| --- | --- | --- | --- |

4.9.2017

EN

Official Journal of the European Union

C 293/34

---

Order of the President of the General Court of 21 July 2017 — PGNiG Supply & Trading v Commission

(Case T-849/16 R)

((Application for interim measures - Internal market in natural gas - Directive 2009/73/EC - Application by the Bundesnetzagentur for review of the exemption of the OPAL pipeline from the EU requirements for its operation - Commission decision amending the exemption from the EU requirements - Application for a stay of execution of a measure - Lack of any urgency))

(2017/C 293/40)

Language of the case: Polish

Parties

Parties

Applicant: PGNiG Supply & Trading GmbH (Munich, Germany) (represented by: M. Jeżewski, lawyer)

Applicant:

Defendant: European Commission (represented by: O. Beynet and K. Herrmann, acting as Agents)

Defendant:

Intervener in support of the defendant: Federal Republic of Germany (represented by: T. Henze and R. Kanitz, acting as Agents)

Intervener in support of the defendant:

Re:

Re:

Request on the basis of Articles 278 TFEU and 279 TFEU seeking a stay of execution of Commission Decision C(2016) 6950 final of 28 October 2016 on review of the exemption of the OPAL pipeline from the requirements on third party access and tariff regulation granted under Directive 2003/55/EC.

Operative part of the order

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | The order of 23 December 2016, PGNiG Supply & Trading GmbH v Commission (T-849/16 R) is revoked. |
| --- | --- |

2.

The order of 23 December 2016, PGNiG Supply & Trading GmbH v Commission (T-849/16 R) is revoked.

| 3. | The costs are reserved. |
| --- | --- |

3.

The costs are reserved.

---
STATE of Louisiana v. Cory HANDY

NO. 2019-KH-0277

Supreme Court of Louisiana.

April 15, 2019

WRIT NOT CONSIDERED. Petitioner has not demonstrated that he sought review in the court(s) below before filing in this Court nor shown the "extraordinary circumstances" that would justify bypassing that level of review. La.S.Ct.R. X § 5(b)
STATE of Louisiana v. Jeffery Lynn JONES

No. 2018-KO-1828

Supreme Court of Louisiana.

April 15, 2019

**ON WRIT OF CERTIORARI TO THE COURT OF APPEAL, THIRD CIRCUIT, PARISH OF RAPIDES**

Writ denied.

Hughes, J., would grant the writ.

The lower courts have allowed the testimony of a police officer, that he "believed what D.C. said during the forensic interview." This was error and undermines confidence in the verdict.
## **EXHIBIT 32.1**

 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES OXLEY ACT OF 2002**

 

In connection with the Annual Report of Metals USA,Inc. (the “Company”) on Form 10-K for the year ended December 31, 2004, asfiled with the Securities and Exchange Commission on the date hereof (the“Annual Report”), I, C. Lourenço Gonçalves, Chief Executive Officer of theCompany, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 ofthe Sarbanes-Oxley Act of 2002, that:

 

1.               The Annual Reportfully complies with the requirements of Section 13(a) or 15(d), as applicable,of the Securities Exchange Act of 1934; and

 

2.               The informationcontained in the Annual Report fairly presents, in all material respects, thefinancial condition, results of operations and cash flows of the Company.

 
| Dated: May 26, 2005 | /S/ C. LOURENCO GONCALVES        |   |
|---------------------|----------------------------------|--------|
|                | C. Lourenço  Gonçalves |
|                | Chief Executive Officer          |

 

The foregoing Certification is being furnished solelypursuant to Section 906 of the Act and is not being filed as part of the Reportor as a separate disclosure statement.

 

A signed original of this written statement requiredby Section 906 has been provided to the Company and will be retained by theCompany and furnished to the Securities and Exchange Commission or its staffupon request.

 

----
<PAGE>

EXHIBIT 1 - Controls and Procedures

Disclosure controls and procedures

Based on their evaluation, as of a date (the "Evaluation Date") within 90 days
prior to the filing date of this Form 40-F, the Chief Executive Officer and
Chief Financial Officer of Axcan Pharma Inc. (the "Company") have concluded that
the Company's disclosure controls and procedures (as defined in Rules 13a-14(c)
and 15d-14(c) under the Securities Exchange Act of 1934) are effective.

Internal controls

There have been no significant changes in internal controls or in other factors
that could significantly affect internal controls subsequent to the Evaluation
Date, including any corrective actions with regard to significant deficiencies
and material weaknesses.
```

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 102 Introduced in House (IH)]

<DOC>

119th CONGRESS
  1st Session
                                H. R. 102

 To amend the Endangered Species Act of 1973 to prevent a species that 
 is not native to the United States from being listed as an endangered 
species or a threatened species, to prohibit certain types of financial 
                  assistance, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 3, 2025

Mr. Biggs of Arizona introduced the following bill; which was referred 
                 to the Committee on Natural Resources

_______________________________________________________________________

                                 A BILL

 
 To amend the Endangered Species Act of 1973 to prevent a species that 
 is not native to the United States from being listed as an endangered 
species or a threatened species, to prohibit certain types of financial 
                  assistance, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``American Sovereignty and Species 
Protection Act of 2025''.

SEC. 2. LIMITATION ON LISTING OF NONNATIVE SPECIES AND PROVISION OF 
              CERTAIN FINANCIAL ASSISTANCE.

    (a) Limitation on Listing of Nonnative Species.--Section 4(a) of 
the Endangered Species Act of 1973 (16 U.S.C. 1533(a)) is amended by 
adding at the end the following:
            ``(4) Nonnative species.--The Secretary may not determine 
        that a species is an endangered species or a threatened species 
        pursuant to this section if such species is not native to the 
        United States.''.
    (b) Limitation on Provision of Certain Financial Assistance.--
Section 8(a) of the Endangered Species Act of 1973 (16 U.S.C. 1537(a)) 
is amended--
            (1) by striking ``As a demonstration of'' and inserting the 
        following:
            ``(1) In general.--As a demonstration of'';
            (2) by striking ``(which includes, but is not limited to, 
        the acquisition, by lease or otherwise, of lands, waters, or 
        interests therein)''; and
            (3) by adding at the end the following:
            ``(2) Prohibition on purchasing land in a foreign 
        country.--No financial assistance provided under paragraph (1) 
        may be used to acquire, by lease or otherwise, lands, waters, 
        or other interests in a foreign country.''.
                                 <all>
```
Exhibit
32.1


CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002







In
connection with the Quarterly Report of China Sun Group High-Tech Co. (the
“Company”) on Form 10-Q for the period ended  February 28, 2009, as
filed with the Securities and Exchange Commission on the date hereof (the
“Report”), I, Bin Wang, President and Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002,
that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.





The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. section 1350 and is not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation language in such
filing.




Date:
      April 14, 2009
                    By:
                    /s/ Bin
      WangBin
      WangPresident
      and Chief Executive Officer
                      (Principal
      Executive Officer)
**EXHIBIT        32.2**

|   | (1) | The                  Report fully complies with the requirements of Section 13(a) or                  15(d) of                  the Securities Exchange Act of 1934;                  and |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The                  information contained in the Report fairly presents, in all material                  respects, the financial condition and result of operations of the                  Company. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                                      |                                           |                                         |
|---------------------------------------------------------------------------|------------------------------------------------|----------------------------------------------|
|                                                                      | **OCCULOGIX,                  INC.**           |
|                                                                 |                                      |                                    |
| Date:   November                  9,                  2007 | By:                                  | /s/ William                  G. Dumencu |
|                                                                      |  Chief                  Financial Officer |
|                                                                      |                                           |

----
#### Orange Belt Auto Line, a Corporation Organized and Existing Under the Laws of the State of Florida, *Plaintiff in Error,*v. Frederick A. Harford, *Defendant in Error.*

En Bane.

Decision Filed August 1, 1927.

Petition for Rehearing Denied October 13, 1927.

*E. W. & R. G. Davis,*for Plaintiff in Error;

*Hull, Landis <& Whitehavr,*for Defendant in Error.

Per Curiam.

This cause having heretofore been submitted to the Court upon the transcript of the record of the judgment herein, and briefs and argument of counsel for the respective parties, and the record having been seen and inspected, and the Court being now advised of its judgment to be given in the premises, it seems to the Court *547that excessive damages are awarded in the said judgment; it is, therefore, considered, ordered and adjudged by the Court that the said judgment of the Circuit Court be, and the same is hereby, affirmed, provided a remittitur of $5,000.00 is entered within thirty days; otherwise, the judgment is reversed. Tampa Elec. Co. v. Gaffga, 81 Fla. 268, 87 South. Rep. 922; 83 Fla. 708.

It is so ordered.

Ellis, C. J., and Whitfield, Strum, Brown and Buford, J. J., concur.
Alvin Eugene TURNER, Appellant, v. STATE of Florida, Appellee.

No. 4D18-2704

District Court of Appeal of Florida, Fourth District.

[March 21, 2019]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
## In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

___________________________

No. 02

- 19

- 00306

- CV

___________________________

Original Proceeding

Trial Court No. 096

- 300703

- 18

Before Su dderth, C.J.; Birdwell and Womack, JJ.

Per Curiam Memorandum Opinion 

### I N RE 

### W ILLIAM 

### L EN 

### R AINEY 

### , Relator2 MEMORANDUM OPINION

The court has considered relator’s petition for writ of mandamus and is of the

opinion that relief should be denied. 1 Accordi ngly, relator’s petition for writ of

man d amus is denied.

Per Curiam

Delivered : August 21, 2019

1 Relator has also filed a “ Motion for Appointment of Attorney in the matter of

Writ of Mandamus & Access to Courts

. ” We deny that motion.
# C_2022037EN.01003002.xml

| 24.1.2022 | EN | Official Journal of the European Union | C 37/30 |
| --- | --- | --- | --- |

24.1.2022

EN

Official Journal of the European Union

C 37/30

---

Judgment of the General Court of 24 November 2021 — YP v Commission

(Case T-581/20) (1)

(Civil service - Officials - Promotion - 2019 promotion exercise - Decision not to promote - Article 45 of the Staff Regulations - Comparison of merits - Use of languages in the context of duties performed by officials assigned to linguistic duties and by officials assigned to duties other than linguistic - Seniority in grade - Presumption of innocence - Article 9 of Annex IX to the Staff Regulations - Duty to state reasons - Compliance with a settlement agreement)

(2022/C 37/41)

Language of the case: French

Parties

Applicant: YP (represented by: J. Van Rossum and J.-N. Louis, lawyers)

Defendant: European Commission (represented by: M. Brauhoff, L. Radu Bouyon and L. Hohenecker, acting as Agents)

Re:

Application under Article 270 TFEU seeking annulment of the Commission’s decision of 14 November 2019 not to include the applicant’s name in the list of officials promoted in the 2019 promotion exercise.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders YP to pay the costs. |
| --- | --- |

2.

Orders YP to pay the costs.

---

(1)  OJ C 371, 3.11.2020.

---
# Fourth Court of Appeals San Antonio, Texas October 10, 2022 No. 04-22-00548-CV HOLLINGSWORTH-PACK CORPORATION and Christopher A. Hewitt, P.E., Appellants

v. Elroy RODRIGUEZ as Trustee of Peter R. Villarreal Irrevocable Life Insurance Trust, Appellee From the 288th Judicial District Court, Bexar County, Texas

Trial Court No. 2022-CI10686 Honorable Nicole Garza, Judge Presiding



### O R D E R The reporter’s record in this appeal was due September 6, 2022. Mr. David J. Laurel is the court reporter responsible for preparing, certifying, and filing the reporter’s record in this appeal. On September 28, 2022, this court notified Mr. Laurel via email that the reporter’s record had not been filed and instructing him to file a Notification of Late Record. We received no response to our letter. It is therefore ORDERED that Mr. Laurel file the record in this court no later than October 20, 2022. If the record is not received by such date, a show cause order shall issue directing Mr. Laurel to appear on a day certain and show cause why he should not be held in contempt for failing to file the record. The clerk of this court shall cause a copy of this order to be served on Mr. Laurel by certified mail, return receipt requested, and by regular United States mail. Because the trial and appellate courts are jointly responsible for ensuring that the appellate record is timely filed, the clerk of this court shall also cause a copy of this order to be served upon the trial court. See T EX . R. A PP . P. 35.3(c).

_________________________________ Lori I. Valenzuela, JusticeIN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 10th day of October, 2022.

___________________________________ MICHAEL A. CRUZ, Clerk of Court